152 related articles for article (PubMed ID: 31879981)
1. Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci.
Céspedes MV; Cano-Garrido O; Álamo P; Sala R; Gallardo A; Serna N; Falgàs A; Voltà-Durán E; Casanova I; Sánchez-Chardi A; López-Laguna H; Sánchez-García L; Sánchez JM; Unzueta U; Vázquez E; Mangues R; Villaverde A
Adv Mater; 2020 Feb; 32(7):e1907348. PubMed ID: 31879981
[TBL] [Abstract][Full Text] [Related]
2. Engineering tumor cell targeting in nanoscale amyloidal materials.
Unzueta U; Seras-Franzoso J; Céspedes MV; Saccardo P; Cortés F; Rueda F; Garcia-Fruitós E; Ferrer-Miralles N; Mangues R; Vázquez E; Villaverde A
Nanotechnology; 2017 Jan; 28(1):015102. PubMed ID: 27893441
[TBL] [Abstract][Full Text] [Related]
3. Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells.
Pesarrodona M; Sánchez-García L; Seras-Franzoso J; Sánchez-Chardi A; Baltá-Foix R; Cámara-Sánchez P; Gener P; Jara JJ; Pulido D; Serna N; Schwartz S; Royo M; Villaverde A; Abasolo I; Vazquez E
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5381-5388. PubMed ID: 31840972
[TBL] [Abstract][Full Text] [Related]
4. Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach.
Unzueta U; Cespedes MV; Sala R; Alamo P; Sánchez-Chardi A; Pesarrodona M; Sánchez-García L; Cano-Garrido O; Villaverde A; Vázquez E; Mangues R; Seras-Franzoso J
J Control Release; 2018 Jun; 279():29-39. PubMed ID: 29641987
[TBL] [Abstract][Full Text] [Related]
5. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases.
Sala R; Rioja-Blanco E; Serna N; Sánchez-García L; Álamo P; Alba-Castellón L; Casanova I; López-Pousa A; Unzueta U; Céspedes MV; Vázquez E; Villaverde A; Mangues R
Drug Deliv; 2022 Dec; 29(1):1384-1397. PubMed ID: 35532120
[TBL] [Abstract][Full Text] [Related]
6. Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.
Céspedes MV; Fernández Y; Unzueta U; Mendoza R; Seras-Franzoso J; Sánchez-Chardi A; Álamo P; Toledo-Rubio V; Ferrer-Miralles N; Vázquez E; Schwartz S; Abasolo I; Corchero JL; Mangues R; Villaverde A
Sci Rep; 2016 Oct; 6():35765. PubMed ID: 27775083
[TBL] [Abstract][Full Text] [Related]
7. Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
Sánchez-García L; Serna N; Álamo P; Sala R; Céspedes MV; Roldan M; Sánchez-Chardi A; Unzueta U; Casanova I; Mangues R; Vázquez E; Villaverde A
J Control Release; 2018 Mar; 274():81-92. PubMed ID: 29408658
[TBL] [Abstract][Full Text] [Related]
8. Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.
Cano-Garrido O; Rodríguez-Carmona E; Díez-Gil C; Vázquez E; Elizondo E; Cubarsi R; Seras-Franzoso J; Corchero JL; Rinas U; Ratera I; Ventosa N; Veciana J; Villaverde A; García-Fruitós E
Acta Biomater; 2013 Apr; 9(4):6134-42. PubMed ID: 23220450
[TBL] [Abstract][Full Text] [Related]
9. Selective delivery of T22-PE24-H6 to CXCR4
Falgàs A; Pallarès V; Serna N; Sánchez-García L; Sierra J; Gallardo A; Alba-Castellón L; Álamo P; Unzueta U; Villaverde A; Vázquez E; Mangues R; Casanova I
Theranostics; 2020; 10(12):5169-5180. PubMed ID: 32373205
[No Abstract] [Full Text] [Related]
10. Selective depletion of metastatic stem cells as therapy for human colorectal cancer.
Céspedes MV; Unzueta U; Aviñó A; Gallardo A; Álamo P; Sala R; Sánchez-Chardi A; Casanova I; Mangues MA; Lopez-Pousa A; Eritja R; Villaverde A; Vázquez E; Mangues R
EMBO Mol Med; 2018 Oct; 10(10):. PubMed ID: 30190334
[TBL] [Abstract][Full Text] [Related]
11. Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4
Sala R; Sánchez-García L; Serna N; Céspedes MV; Casanova I; Roldán M; Sánchez-Chardi A; Unzueta U; Vázquez E; Mangues R; Villaverde A
Acta Biomater; 2019 Nov; 99():426-432. PubMed ID: 31494293
[TBL] [Abstract][Full Text] [Related]
12. Bacterial inclusion bodies are industrially exploitable amyloids.
de Marco A; Ferrer-Miralles N; Garcia-Fruitós E; Mitraki A; Peternel S; Rinas U; Trujillo-Roldán MA; Valdez-Cruz NA; Vázquez E; Villaverde A
FEMS Microbiol Rev; 2019 Jan; 43(1):53-72. PubMed ID: 30357330
[TBL] [Abstract][Full Text] [Related]
13. Bacterial inclusion bodies: an emerging platform for drug delivery and cell therapy.
Villaverde A
Nanomedicine (Lond); 2012 Sep; 7(9):1277-9. PubMed ID: 22994952
[No Abstract] [Full Text] [Related]
14. Receptor and Microenvironment Dual-Recognizable Nanogel for Targeted Chemotherapy of Highly Metastatic Malignancy.
Chen J; Ding J; Xu W; Sun T; Xiao H; Zhuang X; Chen X
Nano Lett; 2017 Jul; 17(7):4526-4533. PubMed ID: 28644032
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.
Rueda F; Céspedes MV; Sánchez-Chardi A; Seras-Franzoso J; Pesarrodona M; Ferrer-Miralles N; Vázquez E; Rinas U; Unzueta U; Mamat U; Mangues R; García-Fruitós E; Villaverde A
Microb Cell Fact; 2016 Apr; 15():59. PubMed ID: 27059706
[TBL] [Abstract][Full Text] [Related]
16. Bacterial Inclusion Bodies: Discovering Their Better Half.
Rinas U; Garcia-Fruitós E; Corchero JL; Vázquez E; Seras-Franzoso J; Villaverde A
Trends Biochem Sci; 2017 Sep; 42(9):726-737. PubMed ID: 28254353
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.
Xia Y; Xiao M; Zhao M; Xu T; Guo M; Wang C; Li Y; Zhu B; Liu H
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110100. PubMed ID: 31753388
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured toxins for the selective destruction of drug-resistant human CXCR4
Serna N; Álamo P; Ramesh P; Vinokurova D; Sánchez-García L; Unzueta U; Gallardo A; Céspedes MV; Vázquez E; Villaverde A; Mangues R; Medema JP
J Control Release; 2020 Apr; 320():96-104. PubMed ID: 31931052
[TBL] [Abstract][Full Text] [Related]
19. Systemic delivery of a Gli inhibitor via polymeric nanocarriers inhibits tumor-induced bone disease.
Vanderburgh JP; Kwakwa KA; Werfel TA; Merkel AR; Gupta MK; Johnson RW; Guelcher SA; Duvall CL; Rhoades JA
J Control Release; 2019 Oct; 311-312():257-272. PubMed ID: 31494183
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release.
Li Y; Lin J; Yang X; Li Y; Wu S; Huang Y; Ye S; Xie L; Dai L; Hou Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):17573-81. PubMed ID: 26234408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
